The GrantWatch blog at Health Affairs has a new post detailing some initiatives from CDDEP's Extending the Cure project: antibiotic use visualizations on ResistanceMap and the Drug Resistance Index.  An excerpt of the post is below - read it in its entirety on the Gran

ResistanceMap's data visualizations on outpatient antibiotic consumption in the United States have been making waves in the U.S.

The following post originally appeared on CDC's Safe Healthcare blog.

The following interview with Ramanan Laxminarayan, Director of CDDEP and its Extending the Cure project, originally appeared on the NewPublicHealth blog of the Robert Wood Johnson Foundation.

New antibiotic use visualizations on ResistanceMap bring to light large variations in outpatient antibiotic dispensing patterns across the United States.  Residents in West Virginia, for example, take over twice the number of antibiotics per capita than people living in western states like Alaska and Oregon.  This infographic breaks down the rates by state, showing a striking pattern of intensive use in the U.S. Southeast in 2006-2007.

Two big updates this week.  First, ResistanceMap has released its first ever interactive visualizations on antibiotic use.  The new maps show trends in outpatient prescribing across the United States over time, and viewers can sort data by geography (at the state level) and/or antibiotic class.  You can check out the new visualizations in the "antibiotic use" module found here.

ResistanceMap - an online tool for visualizing antibiotic resistance from Extending the Cure - launches a second edition today with more bacteria-antibiotic combinations, U.S.-Canada-Europe comparisons of resistance trends, and lots of opportunities to interact with the data.  Read the press release below, and take a look at some initial coverage on The Scientist and the Washington Post's

The following post was originally published on the Pioneering Ideas blog - a discussion about breakthrough ideas in health and health care from the Pioneer Portfolio of the Robert Wood Johnson Foundation.  

The online tool ResistanceMap has released a new video that shows the spread of a deadly microbe able to survive treatment with the newest and most potent antibiotics in the current arsenal.

The rising rate of fluoroquinolone resistance is a serious cause of concern for both human and animal medicine. The discovery and subsequent knowledge of plasmid-mediated quinolone resistance (PMQR) has uncovered a new and more dangerous resistance mechanism that allows bacteria to adapt and survive in the face of clinical concentrations of fluoroquinolones.

The effectiveness and broad-spectrum activity of fluoroquinolones have made this anti-bacterial class one of the most widely used, both in human medicine and veterinary practice. In fact, the fluoroquinolone ciprofloxacin is the most heavily consumed antibacterial agent worldwide. Fluoroquinolones have been used to treat and prevent infections caused by Salmonella enterica, Campylobacter spp., Escherichia coli, Klebsiella spp., Pseudomonas aeruginosa, Neisseria gonorrhoeae and Streptococcus pneumoniae.